Valneva SE (WBO:VLA) Construction In Progress: €0.0 Mil (As of Mar. 2026)


WBO:VLA Valneva SE WBO:VLA
56 GF Score
Price €2.23
GF Value €2.46
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Construction In Progress?

Valneva SE WBO:VLA +1.32% 56 Construction In Progress is €0.0 Mil as of Mar. 2026. GuruFocus rates WBO:VLA with a GF Score™ of 56/100 and a GF Value™ of €2.46 (Fairly Valued). The stock has 6 warning signs investors should review.

Valneva SE's quarterly construction in progress increased from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€1.0 Mil) but then declined from Dec. 2025 (€1.0 Mil) to Mar. 2026 (€0.0 Mil).

Valneva SE's annual construction in progress stayed the same from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil) but then increased from Dec. 2024 (€0.0 Mil) to Dec. 2025 (€1.0 Mil).

Valneva SE Construction In Progress Historical Data

* Premium members only.

The historical data trend for Valneva SE's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Construction In Progress Chart

Valneva SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.66 0.00 0.00 0.00 1.03

Valneva SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.03 0.00
WBO:VLA
56GF Score
Valneva SE WBO:VLA
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valneva SE Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €0.0 Mil mean?
Valneva SE (WBO:VLA) has a Construction In Progress of €0.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Valneva SE and its competitors.
Is Valneva SE's Construction In Progress too high?
Valneva SE's current Construction In Progress is €0.0 Mil. Overall, Valneva SE has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Valneva SE's Construction In Progress compare to VRTX and REGN?
Valneva SE's Construction In Progress of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Valneva SE and its competitors. Valneva SE's current Construction In Progress is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valneva SE stock overvalued right now?
Based on GuruFocus' analysis, Valneva SE (WBO:VLA) is currently considered Fairly Valued. The stock's GF Value™ is €2.46, compared to a current price of €2.23 — trading 9.4% below its estimated fair value. The current Construction In Progress is €0.0 Mil. Valneva SE's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Valneva SE (WBO:VLA), the current Construction In Progress is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valneva SE (WBO:VLA) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of €2.23 is trading 9.4% below its estimated GF Value™ of €2.46. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for WBO:VLA:

  • Construction In Progress: €0.0 Mil
  • GF Value™: €2.46 vs. price of €2.23 (9.4% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the WBO:VLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
56GF Score

Get the complete analysis for WBO:VLA

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.23
Price
€2.46
GF Value